Category
Cancer
Sub Category
Melanoma
Study Name
E3612: A Randomized Phase ll Trial of Ipilimumab with or without Bevacizumab in Patients with Unresectable Stage lll or Stage IV Melanoma
Principal Investigator
Gordon Srkalovic, MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance